reviewTop 1% cited
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
Breast Cancer Research and Treatment · 2018 · Vol. 169(3) · pp. 397–406
Ricardo Costa✉(Moffitt Cancer Center)Hyo S. Han(Moffitt Cancer Center)William J. Gradishar(Northwestern University)
PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysPI3K/AKT/mTOR pathwayTriple-negative breast cancerProtein kinase BBreast cancerCancer researchCancerMedicineOncologyBiologyInternal medicine
MeSH terms
AnimalsFemaleHumansGenetic VariationSignal TransductionBiomarkersGene Expression Regulation, NeoplasticProtein Kinase InhibitorsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseTOR Serine-Threonine KinasesMolecular Targeted TherapyTriple Negative Breast Neoplasms
Citations
450
FWCI
19.30
field-weighted impact
References
73
Percentile
100%
vs. same field & year
Citations per year
Cited by
References
The Identification of 2-(1<i>H</i>-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer
Journal of Medicinal Chemistry · 2008 · 741 citations
Comprehensive molecular portraits of human breast tumours
Nature · 2012 · 12,217 citations
Molecular portraits of human breast tumours
Nature · 2000 · 16,173 citations
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Journal of Clinical Oncology · 2008 · 2,876 citations
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
Cancer Research · 2006 · 2,544 citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Journal of Clinical Investigation · 2011 · 5,405 citations
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
JNCI Journal of the National Cancer Institute · 2000 · 1,215 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.